EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Preoperative Analgesia Efficacy of Liposomal Bupivacaine Following Pericapsular Nerve Group (PENG) Block in Patients with Hip Fracture: A Randomized Controlled Observer-Blinded Study

Haobin Peng, Jiajun Wen, Manli Chen, Zhengyuan Xia, Ying Jiang, Kaiqi Xie, Weitao Huang, Bangsheng Cui, Peixing Li, Yiwen Zhang, Xianping Wu

Pain and Therapy · 2025-02 · 14 (1) · 283-296

DOI: 10.1007/s40122-024-00683-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain and Therapy, online erschienen am 03.12.2024. Verfasst von Haobin Peng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shunde Hospital of Guangzhou University of Traditional Chinese Medicine, Foshan, 528300, Guangdong, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Red Cross Foundation of China Medical Empowerment Public Welfare Special Fund, 2024 Medical research project of Foshan Health Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Single-injection pericapsular nerve group (PENG) block with ropivacaine provides clear analgesic effects in preoperative pain management for hip fractures. However, it suffers from insufficient duration, failing to meet the needs of most patients. This single-center, randomized controlled, observer-blinded trial utilizes a novel combination of liposomal bupivacaine (LB) single-injection PENG block to examine its efficacy, duration, and safety in preoperative analgesia for hip fractures, aiming to develop a new preoperative analgesic protocol. METHODS: Sixty-six patients with hip fractures received ultrasound-guided single-injection PENG block with LB or ropivacaine after admission. The primary outcome was the static and dynamic pain scores measured at 48 h post-block. Pain scores at 12, 24, 36, 60, and 72 h post-block, rescue analgesia rate, time to first opioid, additional morphine consumption, and adverse events were assessed as the secondary outcomes. RESULTS: LB versus ropivacaine group at 48 h post-block, with a median interquartile range (IQR) of 2 (1.0-2.0) versus 3 (2.0-3.0) at static pain score and 2 (1.75-3.0) versus 4 (4.0-5.0) at dynamic pain score. LB group had lower dynamic and static pain scores at other observation points except for the static pain score at 72 h, lower pain intensity [sum of pain intensity difference (SPID)0-24, SPID0-48 and SPID0-72], longer time to first opioid, lower additional morphine consumption, and lower incidence of nausea and vomiting. No significant inter-group differences were detected in other secondary outcomes. CONCLUSIONS: For preoperative analgesia of hip fractures, LB single-injection PENG block had a similar analgesic intensity and safety as ropivacaine but provided a longer duration of analgesia, reaching 48 h and even extending beyond 60 h, which reduced opioid consumption and extended time to the first opioid. TRIAL REGISTRATION: The protocol was registered in www.chictr.org.cn under the identifier ChiCTR2300072939.

Schlagwörter

Stichwörter der Autor:innen

Hip fractureLiposomal bupivacainePericapsular nerve group blockPreoperative analgesia

Autor:innen und Institutionen

  • Department of Anesthesiology, Shunde Hospital of Guangzhou University of Traditional Chinese Medicine, Foshan, 528300, Guangdong, China.
  • Department of Anesthesiology, University of Hong Kong, Hong Kong, China.
  • Department of Orthopedics, Shunde Hospital of Guangzhou University of Traditional Chinese Medicine, Foshan, 528300, Guangdong, China.
  • Department of Anesthesiology, Shunde Hospital of Southern Medical University, Foshan, 528300, Guangdong, China. ssss047@163.com.
  • Department of Anesthesiology, Shunde Hospital of Guangzhou University of Traditional Chinese Medicine, Foshan, 528300, Guangdong, China. sdwxp@163.com.

Förderung

  • The Red Cross Foundation of China Medical Empowerment Public Welfare Special Fund
  • 2024 Medical research project of Foshan Health Bureau

Zitieren

APA

Peng, H., Wen, J., Chen, M., Xia, Z., Jiang, Y., Xie, K., Huang, W., Cui, B., Li, P., Zhang, Y., & Wu, X. (2025). Preoperative Analgesia Efficacy of Liposomal Bupivacaine Following Pericapsular Nerve Group (PENG) Block in Patients with Hip Fracture: A Randomized Controlled Observer-Blinded Study. Pain and Therapy, 14(1), 283-296. https://doi.org/10.1007/s40122-024-00683-6

Vancouver

Peng H, Wen J, Chen M, Xia Z, Jiang Y, Xie K, et al. Preoperative Analgesia Efficacy of Liposomal Bupivacaine Following Pericapsular Nerve Group (PENG) Block in Patients with Hip Fracture: A Randomized Controlled Observer-Blinded Study. Pain and Therapy. 2025;14(1):283-296. doi:10.1007/s40122-024-00683-6

BibTeX
@article{Peng2025,
  author = {Peng, Haobin and Wen, Jiajun and Chen, Manli and Xia, Zhengyuan and Jiang, Ying and Xie, Kaiqi and Huang, Weitao and Cui, Bangsheng and Li, Peixing and Zhang, Yiwen and Wu, Xianping},
  title = {Preoperative Analgesia Efficacy of Liposomal Bupivacaine Following Pericapsular Nerve Group (PENG) Block in Patients with Hip Fracture: A Randomized Controlled Observer-Blinded Study},
  journal = {Pain and Therapy},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {283--296},
  doi = {10.1007/s40122-024-00683-6}
}
Kostenlos starten →